🇺🇸 FDA
Patent

US 12152038

Vasopressin receptor antagonists and products and methods related thereto

granted A61PA61P25/00A61P25/18

Quick answer

US patent 12152038 (Vasopressin receptor antagonists and products and methods related thereto) held by Neumora Therapeutics, Inc. expires Mon Nov 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Neumora Therapeutics, Inc.
Grant date
Tue Nov 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
123
CPC classes
A61P, A61P25/00, A61P25/18, A61P25/20, A61P25/22